Centessa Pharmaceuticals PLC ADR (CNTA) Insider Trading
- $9,101,824.86
- $20,600,336.62
- Aug. 15, 2025
- Saurabh Saha
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Aug. 20, 2024 | CEO | 4,169 | $12.32 | Sell | $51,362.08 | |
March 25, 2024 | Insider | 51,160 | $11.88 | Sell | $607,780.80 | |
Feb. 1, 2024 | SVP | 4,267 | $8.10 | Sell | $34,562.70 | |
Sept. 20, 2023 | SVP | 37,484 | $6.29 | Sell | $235,774.36 | |
June 1, 2023 | EVP | 6,500 | $4.45 | Sell | $28,925.00 | |
May 24, 2023 | Insider | 8,000 | $4.48 | Sell | $35,840.00 | |
May 1, 2023 | EVP | 6,800 | $4.42 | Sell | $30,056.00 | |
Jan. 4, 2023 | EVP | 6,970 | $3.18 | Sell | $22,164.60 | |
Dec. 1, 2022 | EVP | 9,400 | $3.91 | Sell | $36,754.00 | |
Nov. 1, 2022 | EVP | 9,700 | $4.03 | Sell | $39,091.00 | |
Oct. 3, 2022 | General Counsel | 4,563 | $3.95 | Sell | $18,023.85 | |
Oct. 3, 2022 | EVP | 12,524 | $3.92 | Sell | $49,094.08 | |
Oct. 3, 2022 | Insider | 4,167 | $3.95 | Sell | $16,459.65 | |
Oct. 3, 2022 | CFO | 4,901 | $3.95 | Sell | $19,358.95 | |
Oct. 3, 2022 | CTO | 2,455 | $3.95 | Sell | $9,697.25 | |
Sept. 30, 2022 | CTO | 2,003 | $4.07 | Sell | $8,152.21 | |
Sept. 30, 2022 | EVP | 2,468 | $4.07 | Sell | $10,044.76 | |
Sept. 30, 2022 | Insider | 3,401 | $4.07 | Sell | $13,842.07 | |
Sept. 30, 2022 | CFO | 4,000 | $4.07 | Sell | $16,280.00 | |
Sept. 30, 2022 | General Counsel | 3,725 | $4.07 | Sell | $15,160.75 | |
Aug. 1, 2022 | EVP | 10,423 | $4.45 | Sell | $46,382.35 | |
July 18, 2022 | EVP | 20,000 | $4.87 | Sell | $97,400.00 | |
July 1, 2022 | EVP | 9,100 | $5.03 | Sell | $45,773.00 | |
June 24, 2022 | CEO | 10,000 | $4.63 | Buy | $46,300.00 | |
June 17, 2022 | EVP | 9,200 | $4.68 | Sell | $43,056.00 | |
May 17, 2022 | EVP | 20,222 | $5.42 | Sell | $109,603.24 | |
Feb. 2, 2022 | CEO | 5,000 | $9.74 | Buy | $48,700.00 | |
Jan. 28, 2022 | Insider | 27,500 | $9.05 | Buy | $248,875.00 | |
Dec. 2, 2021 | Major Shareholder | 34,326 | $12.82 | Buy | $440,059.32 | |
Dec. 1, 2021 | Director | 60,304 | $12.62 | Buy | $761,036.48 | |
Nov. 30, 2021 | Major Shareholder | 36,847 | $11.62 | Buy | $428,162.14 | |
Nov. 29, 2021 | Director | 56,706 | $11.70 | Buy | $663,460.20 | |
Nov. 26, 2021 | Director | 11,817 | $11.34 | Buy | $134,004.78 | |
Nov. 18, 2021 | Director | 10,000 | $11.98 | Buy | $119,800.00 | |
Nov. 16, 2021 | Insider | 5,000 | $12.46 | Buy | $62,300.00 | |
Nov. 16, 2021 | CEO | 23,000 | $12.28 | Buy | $282,440.00 |
Insiders are both buying and selling Centessa Pharmaceuticals PLC ADR stock.
The insider traders at Centessa Pharmaceuticals PLC ADR are: Saurabh Saha, Gregory M Weinhoff, Antoine Yver, Iqbal J Hussain, Karen M Anderson, Tia L Bush, David M Chao, Rubertis Francesco De, Medicxi Ventures Management (J, Harris Rotman, Mario Alberto Accardi, Arjun Goyal, Thomas Templeman, David J Grainger, and Aaron Kantoff
The most active insider trader at Centessa Pharmaceuticals PLC ADR is Saurabh Saha with 21 trades.
Saurabh Saha has sold the most Centessa Pharmaceuticals PLC ADR stock with a total value of $13,773,977.11.
Arjun Goyal has bought the most Centessa Pharmaceuticals PLC ADR stock with a total value of $11,183,320.52.
The most recent insider trade for Centessa Pharmaceuticals PLC ADR was on Aug. 15, 2025.
The single biggest insider buy for Centessa Pharmaceuticals PLC ADR was from Arjun Goyal with a total value of $5,316,633.58 on May 16, 2025.
The single biggest insider sell for Centessa Pharmaceuticals PLC ADR was from Saurabh Saha with a total value of $2,891,000.00 on Sept. 10, 2024.